Abstract:Objective To investigate the clinical effect of Pavlik sling in the treatment of developmental dysplasia of the hip in infants aged 0-6 months.Methods Eighty infants with developmental dysplasia of the hip from 0 to 6 months were selected for diagnosis and treatment in the hospital.By means of random grouping, all the infants were divided into two groups: control group and observation group, 40 cases in each group.The observation group was treated with Pavlik sling, while in the control group, closed reduction and plaster fixation in human position was performed,and the follow-up period was observed.Ultrasound examination of hip joint development was performed every two weeks.Suspension treatment lasted for six to twenty weeks.The average follow-up time ranged from eight months.The total effective rate and complication rate of the two groups after different treatment were compared and observed.Results The total effective rate of the observation group was higher than that of the control group, and the total incidence of complications was lower than that of the control group (P<0.05).Conclusion Pavlik sling treatment can significantly improve the treatment efficiency of infants reduce the long-term residual deformities of infants in the treatment process,and reduce the incidence of complications, which is worthy of wide promotion and application in the medical field.
刘再新; 高福堂. Pavlik吊带治疗0~6个月婴幼儿发育性髋关节发育不良的临床效果[J]. 中国当代医药, 2020, 27(8): 102-104.
LIU Zai-xin; GAO Fu-tang. Clinical effect of Pavlik sling in the treatment of developmental dysplasia of hip in infants aged 0-6 months. 中国当代医药, 2020, 27(8): 102-104.
Ning B,Yuan Y,Yao J,et al.Analyses of outcomes of onestage operation for treatment of late-diagnosed developmental dislocation of the hip:864 hips followed for 3.2 to 8.9 years[J].BMC Musculoskelet Disord,2014,15:401.
Atalar H,Gunay C,Yavuz OY,et al.Maternal height and infant body mass index are possible risk factors for developmental dysplasia of the hip in female infants[J].Acta Medica Okayama,2015,69(6):349-349.